Medical condition
Axial Spondyloarthritis
Axial Spondyloarthritis is a medical condition tracked by NovaPharmaNews across 8 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- upadacitinib (RINVOQ) Antineoplastic and immunomodulating agents (L04)
- secukinumab (COSENTYX) Antineoplastic and immunomodulating agents (L04)
- certolizumab pegol (CIMZIA) Antineoplastic and immunomodulating agents (L04)
- etanercept (BRENZYS) Antineoplastic and immunomodulating agents (L04)
- ixekizumab (TALTZ) Antineoplastic and immunomodulating agents (L04)
- golimumab (SIMPONI) Antineoplastic and immunomodulating agents (L04)
- bimekizumab (BIMZELX) Antineoplastic and immunomodulating agents (L04)
- adalimumab (ABRILADA) Antineoplastic and immunomodulating agents (L04)